Balyasny Asset Management
LUNG icon

Balyasny Asset Management’s Pulmonx LUNG Stock Holding History

Balyasny Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,672
Closed -$414K – 2888
2024
Q1 		$414K Buy
+44,672
New +$524K ﹤0.01% 2126
2022
Q1 		– Sell
-221,186
Closed -$7.09M – 2683
2021
Q4 		$7.09M Buy
+221,186
New +$8.08M 0.02% 736

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Balyasny Asset Management's LUNG Position: Q2 2024 in Review

Balyasny Asset Management sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 44,672 shares — an estimated $414K sold.

Balyasny Asset Management first reported a position in LUNG in Q4 2021 and held it in 2 quarters. The position peaked at $7.09M in Q4 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Balyasny Asset Management reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 44,672 Pulmonx shares in Q2 2024, an estimated $414K.
  • Balyasny Asset Management first reported a position in Pulmonx in Q4 2021 and held it in 2 quarters.
  • Balyasny Asset Management's Pulmonx position peaked at $7.09M in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.